Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00231127
Status:
COMPLETED
Last Update Posted:
2009-11-10
First Post:
2005-10-03
Brief Title:
Osteoporosis and Chronic Obstructive Pulmonary Disease COPD
Sponsor:
Catharina Ziekenhuis Eindhoven
Organization:
Catharina Ziekenhuis Eindhoven
Study Overview
Official Title:
Osteoporosis and COPD Making of a Database
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goals of the trial are
To determine the prevalence of osteoporosis in subgroups of COPD patients
To look for risk factors of osteoporosis in COPD patients
To create sub-groups for prospective research concerning the effects of bisphosphonates on osteoporosis variables in COPD patients
To determine the prevalence of osteoporosis in subgroups of COPD patients
To look for risk factors of osteoporosis in COPD patients
To create sub-groups for prospective research concerning the effects of bisphosphonates on osteoporosis variables in COPD patients
Detailed Description:
Background
Osteoporosis is defined as a systemically skeletal disorder characterized by a low bone mass and deterioration of the micro-architecture of the bone and is therefore associated with a higher risk of fractures Large epidemiological studies to determine the incidence and prevalence of osteoporosis in COPD patients in different stages of their disease are not available The etiology of osteoporosis in COPD patients is complex and depends on multiple factors
Goals of the Trial
To determine the prevalence of osteoporosis in subgroups of COPD patients
To look for risk factors of osteoporosis in COPD patients
To create sub-groups for prospective research concerning the effects of bisphosphonates on osteoporosis variables in COPD patients
Study Design
Patients diagnosed with COPD according to the American Thoracic Society ATS guidelines and divided in stages according to the Global Initiative on Obstructive Lung Diseases GOLD-classification who visit the out-patient clinic of pulmonology of the Catharina Hospital Eindhoven will be asked to participate in the trial A database will be created prospectively of the medical information about these patients which will be analysed retrospective To gather information we will use the medical records a questionnaire a blood sample long function testing including a 6-minute walking test and a DEXA-scan
Osteoporosis is defined as a systemically skeletal disorder characterized by a low bone mass and deterioration of the micro-architecture of the bone and is therefore associated with a higher risk of fractures Large epidemiological studies to determine the incidence and prevalence of osteoporosis in COPD patients in different stages of their disease are not available The etiology of osteoporosis in COPD patients is complex and depends on multiple factors
Goals of the Trial
To determine the prevalence of osteoporosis in subgroups of COPD patients
To look for risk factors of osteoporosis in COPD patients
To create sub-groups for prospective research concerning the effects of bisphosphonates on osteoporosis variables in COPD patients
Study Design
Patients diagnosed with COPD according to the American Thoracic Society ATS guidelines and divided in stages according to the Global Initiative on Obstructive Lung Diseases GOLD-classification who visit the out-patient clinic of pulmonology of the Catharina Hospital Eindhoven will be asked to participate in the trial A database will be created prospectively of the medical information about these patients which will be analysed retrospective To gather information we will use the medical records a questionnaire a blood sample long function testing including a 6-minute walking test and a DEXA-scan
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None